We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$785M
AUM Growth
+$300M
Cap. Flow
+$256M
Cap. Flow %
32.59%
Top 10 Hldgs %
45.64%
Holding
72
New
25
Increased
20
Reduced
11
Closed
13

Top Buys

Rank Stock Value
1
ASRT
Assertio
ASRT
+$27M
2
ENR icon
Energizer
ENR
+$19M
3
PLYA
Playa Hotels & Resorts
PLYA
+$13.2M
4
BBBY
Bed Bath & Beyond Inc
BBBY
+$12.7M
5
GCI
Gannett Co., Inc
GCI
+$12.7M

Top Sells

Rank Stock Value
1
KATE
Kate Spade & Company
KATE
+$13.3M
2
DECK icon
Deckers Outdoor
DECK
+$10.8M
3
VSTO
Vista Outdoor Inc.
VSTO
+$9.27M
4
ATRS
Antares Pharma, Inc.
ATRS
+$8.5M
5
SAM icon
Boston Beer
SAM
+$7.81M

Sector Composition

Rank Sector Weight
1 Healthcare 31.65%
2 Consumer Discretionary 21.97%
3 Consumer Staples 11.32%
4 Industrials 3.49%
5 Communication Services 1.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$135M 17.26%
560,000
+280,000
+100% +$67.1M
VNDA icon
2
Vanda Pharmaceuticals
VNDA
$327M
$33.6M 4.29%
2,064,000
+456,000
+28% +$6.57M
DECK icon
3
CALL
Deckers Outdoor
DECK
$14.8B
$27.3M 3.48%
2,400,000
+1,800,000
+300% +$18.8M
ASRT
4
DELISTED
Assertio
ASRT
$26.1M 3.33%
+40,533
New +$27M
HAIN icon
5
Hain Celestial
HAIN
$50.6M
$26.1M 3.32%
672,000
+264,000
+65% +$9.54M
CPB icon
6
CALL
Campbell Soup
CPB
$6.58B
$25M 3.19%
+480,000
New +$27.2M
FRPT icon
7
Freshpet
FRPT
$2.78B
$22.1M 2.82%
1,332,000
-144,000
-10% -$1.98M
REGN icon
8
Regeneron Pharmaceuticals
REGN
$70.9B
$21.6M 2.75%
44,000
+4,000
+10% +$1.75M
NOMD icon
9
Nomad Foods
NOMD
$1.61B
$20.5M 2.62%
1,456,000
+332,000
+30% +$4.24M
ADMS
10
DELISTED
Adamas Pharmaceuticals
ADMS
$20.3M 2.58%
1,158,000
+294,000
+34% +$4.86M
PII icon
11
Polaris
PII
$4.16B
$19.9M 2.54%
216,000
+84,000
+64% +$7.2M
SGI
12
Somnigroup International
SGI
$15.3B
$18.7M 2.38%
1,400,000
+216,000
+18% +$2.55M
ATRS
13
DELISTED
Antares Pharma, Inc.
ATRS
$18.4M 2.34%
5,700,000
-3,000,000
-34% -$8.5M
NVLN
14
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$17.1M 2.18%
1,852,000
– –
ENR icon
15
Energizer
ENR
$1.39B
$16.8M 2.14%
+350,000
New +$19M
PRKS icon
16
United Parks & Resorts
PRKS
$2.13B
$16.3M 2.07%
1,000,000
+520,000
+108% +$8.93M
PLYA
17
DELISTED
Playa Hotels & Resorts
PLYA
$14.9M 1.9%
+1,250,000
New +$13.2M
HBI
18
DELISTED
Hanesbrands
HBI
$13.9M 1.77%
600,000
-100,000
-14% -$2.16M
MNTA
19
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$13.9M 1.77%
+820,000
New +$12.5M
GCI
20
DELISTED
Gannett Co., Inc
GCI
$13.4M 1.71%
+1,536,000
New +$12.7M
AVDL
21
DELISTED
Avadel Pharmaceuticals
AVDL
$12.7M 1.62%
1,150,000
+194,000
+20% +$1.95M
ALXN
22
DELISTED
Alexion Pharmaceuticals
ALXN
$12.2M 1.55%
100,000
-6,000
-6% -$698K
SBBP
23
DELISTED
Strongbridge Biopharma plc.
SBBP
$12.1M 1.54%
1,692,000
+52,000
+3% +$240K
QVCGA
24
DELISTED
QVC Group Inc Series A
QVCGA
$11.5M 1.46%
+9,641
New +$10.7M
BBY icon
25
Best Buy
BBY
$18B
$11.5M 1.46%
200,000
+50,000
+33% +$2.67M
1
2 3

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Armistice Capital held 72 positions worth $785M, up 62% from $484M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Armistice Capital deployed $256M of net new capital in Q2 2017, opening 25 new positions and adding to 20 existing holdings. Its largest new stake was Assertio: 40,533 shares worth $26.1M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Antares Pharma, Inc., an estimated $8.5M trimmed.

  • Armistice Capital's largest Q2 2017 buy was Assertio: 40,533 shares worth $26.1M.
  • Armistice Capital added most to Hain Celestial in Q2 2017, an estimated $9.54M increase.
  • Armistice Capital's biggest Q2 2017 reduction was Antares Pharma, Inc., cutting an estimated $8.5M.
  • Armistice Capital fully exited Kate Spade & Company in Q2 2017, selling an estimated $13.3M.
  • Armistice Capital's ten largest holdings make up 46% of its $785M portfolio in Q2 2017.
  • Armistice Capital opened 25 new positions and closed 13 in Q2 2017.
  • Armistice Capital's portfolio value rose 62% quarter-over-quarter to $785M.

Based on Armistice Capital's 13F filing for Q2 2017, filed 14 Aug 2017.